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Abstract: We aimed to investigate the relationship between dietary saturated fat on fasting triglyceride (TG) and cholesterol levels, and 
any mediation of this relationship by dietary carbohydrate intake. Men and women in the NHLBI Genetics of Lipid-Lowering Drugs and 
Diet Network (GOLDN) study (n = 1036, mean age ± SD = 49 ± 16 y) were included. Mixed linear models were run with saturated fat 
as a predictor variable and fasting TG, very low density lipoprotein cholesterol (VLDL-C), low density cholesterol (LDL-C) and high 
density cholesterol (HDL-C) as separate outcome variables. Subsequent models were run which included dietary carbohydrate as a pre-
dictor variable, and an interaction term between saturated fat and carbohydrate. All models controlled for age, sex, BMI, blood pressure 
and dietary covariates. In models that included only saturated fat as a predictor, saturated fat did not show significant associations with 
fasting lipids. When carbohydrate intake and an interaction term between carbohydrates and saturated fat intake was included, carbo-
hydrate intake did not associate with lipids, but there was an inverse relationship between saturated fat intake and VLDL-C (P = 0.01) 
with a significant interaction (P = 0.01) between saturated fat and carbohydrate with regard to fasting VLDL-C concentrations. Similar 
results were observed for fasting TG levels. We conclude that, when controlling for carbohydrate intake, higher saturated fat was associ-
ated with lower VLDL-C and TGs. This was not the case at higher intakes of carbohydrate. This has important implications for dietary 
advice aimed at reducing TG and VLDL-C levels.
Keywords: carbohydrate, saturated fat, cholesterol, interaction, triglycerides, VLDL
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Introduction
Cardiovascular disease (CVD) is associated with a 
dyslipidemic profile that includes increased LDL-C 
and decreased HDL-C and may include high TGs.1 
Early animal models showed that a high saturated fat 
intake can lead to increased serum cholesterol and the 
development of atherosclerotic plaques.2 These were 
initially substantiated by epidemiological3–10 and clin-
ical intervention11–14 studies in humans and reducing 
dietary fat, especially saturated fat, remains the main-
stay of dietary advice aimed at reducing CVD risk.
However, more recent studies have started to chal-
lenge the idea that saturated fat intake is, in itself, a 
risk factor for dyslipidemia. Low carbohydrate diets, 
where a portion of energy from carbohydrates is 
exchanged for energy from saturated fat, are associ-
ated with a decrease in a number of CVD risk fac-
tors, including decreased blood pressure, increased 
HDL-C and TG,15 just as the exchange of fat, par-
ticularly saturated fat, for carbohydrate is associ-
ated with an increase in TG, VLDL-C and LDL-C in 
lipid profiles in hypercholesterolemic and hyperlipi-
demic (raised LDL-C and TG) patients.16 Given that 
there were differences between the hypercholester-
olemic and hyperlipidemic groups, it is important to 
 replicate this in healthy groups before the results can 
be generalized to the general population. The reasons 
underlying the beneficial effects of low carbohydrate 
diets are not clear, but may arise through de novo 
VLDL-TG lipogensis (shown mostly from the inges-
tion of simple sugars),17 or through reduced plasma 
VLDL-TG clearance, shown with both diets high in 
simple sugar, and high in solid-food high-fiber carbo-
hydrate sources, but low in simple sugars.18  Without 
the increased secretion of VLDL-TG and hepatic 
uptake of free fatty acids,19 dietary fat intake may not 
increase dyslipidemia. Understanding the relation-
ship between carbohydrate and saturated fat intake 
together, and their effects on serum lipids, is thus cru-
cial for the dietary management of CVD risk.
This study examined the relationship between dietary 
fat, dietary carbohydrate and lipidemia (TG, VLDL-C, 
LDL-C and HDL-C) using data from a large cross-
sectional study. In addition we examined whether any 
relationship between saturated fat intake and lipids was 
mediated by carbohydrate intake. We used linear mixed 
models to test whether, based on  habitual dietary intake, 
there is an association between saturated fat intake 
and fasting plasma TG and cholesterol levels when 
controlling for other dietary covariates. We further ran 
mixed linear models that included an interaction term 
between carbohydrate and fat intake to examine whether 
the association between dietary fat on serum lipids var-
ies across levels of dietary carbohydrate intake.
Results
Participant characteristics
Table 1 shows characteristics of men and women who 
participated in the Genetics of Lipid Lowering Drugs 
network (GOLDN) study. There were significant dif-
ferences (P , 0.05) between men and women with 
regard to intake of macronutrients and lipid profiles; 
notably men had a significantly lower percentage of 
their total energy from carbohydrates and polyunsat-
urated fatty acids (PUFAs), but a higher percentage 
of their overall diet was composed of monounsatu-
rated fatty acids (MUFAs) and trans fatty acids. Men 
had higher fasting TGs, VLDL-C, LDL-C and lower 
HDL-C than women. In addition, men had higher 
fasting insulin and glucose levels.
Table 2 shows the distribution of potential 
 confounders by tertiles of energy from carbohydrate. 
Individuals with lower proportion of energy from 
 carbohydrate were significantly more likely to be 
male, current or past smokers and current drinkers; 
therefore models looking at the moderation of the 
association between saturated fat and TGs by carbo-
hydrate intake controlled for these factors.
Main effects of saturated fat on lipids
Mixed models were fitted which looked for an asso-
ciation between saturated fat and lipids. From the fully 
adjusted model, saturated fat intake did not show a sig-
nificant association with fasting TG (P = 0.56), VLDL-C 
(P = 0.32), LDL-C (P = 0.57) or HDL-C (P = 0.46).
Main effects of saturated fat  
on fasting lipids when controlling  
for carbohydrate Intake
In fully adjusted models that included a saturated 
fat -carbohydrate interaction term, carbohydrate 
intake showed no main effect on TG (P = 0.56; 
Table 3), VLDL-C (P = 0.25; Table 3), LDL-C 
(P = 0.41; Table 3) or HDL-C (P = 0.31; Table 3). 
Saturated fat showed a significant main effect on 
VLDL-C, with higher saturated fat being associated 
carbohydrate intake, saturated fat and cholesterol
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Age, y 49.2 (16.2) 48.3 (16.2) ,0.001
current smokers, % 6.8 7.8 0.56
current drinkers, % 48.1 51.0 0.35
BMI, kg/m2 28.6 (4.9) 28.1 (6.3) ,0.001
Systolic blood pressure, (mmhg) 71.2 (9.6) 66.2 (9.1) ,0.0001
Diastolic blood pressure, (mmhg) 119.5 (15.4) 113.0 (17.2) ,0.0001
Total food energy intake; kcal/day 2364 (969) 1780 (707) ,0.001
carbohydrates, % energy 47.6 (8.4) 50.2 (8.1) ,0.001
Saturated fat, % energy 12.2 (2.7) 11.6 (2.7) ,0.001
Protein, % energy 15.9 (2.7) 15.8 (2.9) ,0.001
PUFA, % energy 7.4 (2.0) 7.9 (2.2) ,0.001
MUFA, % energy 13.7 (0.3) 13.0 (2.8) ,0.001
Trans fat, % energy 2.2 (0.6) 2.3 (2.0) ,0.001
glycemic load 137 (60.4) 107 (1.4) ,0.001
Fasting Tgs (mmol/L) 1.7 (1.6) 1.4 (0.9) 0.30
Fasting VLDL-c (mmol/L) 3.2 (3.2) 2.3 (2.0) ,0.0001
Fasting LDL-c (mmol/L) 3.2 (0.8) 3.1 (0.8) ,0.001
Fasting hDL-c (mmol/L) 1.1 (0.3) 1.4 (0.4) ,0.001
Fasting glucose (mg/dL) 105.2 (19.7) 97.8 (15.92) ,0.001
Fasting insulin (mU/L) 14.2 (8.6) 13.4 (7.8) ,0.001
Abbreviations: BMI, Body mass index; PUFA, Polyunsaturated fatty acids; MUFA, Monounsaturated fatty acids; Tgs, Triglycerides; VLDL-c, Very low 
density lipoprotein cholesterol; LDL-c, Low density lipoprotein cholesterol; hDL-c, high density lipoprotein cholesterol.
Table 2. Participant characteristic by tertiles of percent energy from carbohydrate intake.
Tertile 1  
(n = 345)
Tertile 2  
(n = 345)
Tertile 3  
(n = 346)
P-value
carbohydrates, % energy 40 (5.3) 49.11 (1.9) 57.71 (4.7) ,0.001
gender, % male 56.5 46.5 40.9 ,0.001
Age, y 48.1 (13.3) 47.9 (15.6) 50.2 (19.1) 0.11
current smokers, % 12.5 4.9 4.7 ,0.001
current drinkers, % 60.9 48.0 40.0 ,0.001
BMI, kg/m2 29.0 (6.0) 27.8 (5.3) 28.2 (5.6) 0.02
Systolic blood pressure, (mmhg) 69.3 (9.7) 68.5 (9.5) 68.0 (9.8) 0.10
Diastolic blood pressure, (mmhg) 115.5 (16.4) 115.4 (16.0) 117.47 (17.5) 0.08
Total energy intake, kcal/d 2244 (956) 2099 (867) 1838 (801) ,0.001
Saturated fat, % energy 13.6 (2.6) 12.1 (2.0) 10.0 (2.0) ,0.001
Protein; % energy 17.0 (3.0) 15.8 (2.2) 14.7 (2.7) ,0.001
PUFA, % energy 8.9 (2.4) 7.6 (1.7) 6.4 (1.5) ,0.001
MUFA, % energy 15.6 (2.6) 13.4 (1.6) 11.0 (1.9) ,0.001
Transfat, % energy 2.3 (0.6) 2.2 (0.5) 1.9 (0.5) ,0.001
glycemic load of diet 108 (49.0) 127 (54.6) 131 (60.6) ,0.001
Fasting Tgs (mmol/L) 1.6 (1.3) 1.6 (1.6) 1.6 (1.0) 0.42
Fasting VLDL-c (mmol/L) 2.9 (2.8) 2.7 (3.0) 2.7 (2.2) 0.31
Fasting LDL-c (mmol/L) 3.2 (0.8) 3.1 (0.8) 3.1 (0.8) 0.34
Fasting hDL-c (mmol/L) 1.2 (0.3) 1.2 (0.3) 1.2 (0.3) 0.96
Fasting glucose (mg/dL) 104.3 (21.7) 99.9 (16.8) 99.8 (15.1) 0.001
Fasting insulin (mu/L) 14.3 (9.8) 13.3 (7.7)  13.7 (6.9) 0.25
Abbreviations: BMI, Body mass index; PUFA, Polyunsaturated fatty acids; MUFA, Monounsaturated fatty acids acids; Tgs, Triglycerides; VLDL-c, Very 
low density lipoprotein cholesterol; LDL-c, Low density lipoprotein cholesterol; hDL-c, high density lipoprotein cholesterol.
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with lowered VLDL-C (P = 0.01; Table 3) but not on 
TG (P = 0.08; Table 3), LDL-C (P = 0.75; Table 3) 
nor HDL-C (P = 0.14; Table 3).
Interactions between carbohydrate  
and saturated fat on fasting lipids
Although continuous dietary variables were used in 
the mixed models, graphs are presented using tertiles 
of carbohydrate intake (as above) and saturated fat 
divided into ‘high’ and ‘low’ categories. Saturated 
fat was divided into these categories by splitting the 
ordered distribution of fat intake into two equal-sized 
categories. This is done for easy interpretation.
Fully adjusted models revealed a significant inter-
action was observed between carbohydrate intake 
and saturated fat intake on fasting TG concentrations 
(P = 0.04; Table 3, Fig. 1). Over the whole sample, 
saturated fat did not significantly affect fasting TG 
concentrations. However, the effect of saturated fat 
intake on fasting TGs was mediated by carbohydrate 
intake; at low carbohydrate intakes, higher intake of 
saturated fat was associated with lower fasting TGs, 
but this effect had disappeared by the highest tertile 
of carbohydrate intake (Fig. 1). The interaction was 
similarly significant for VLDL-C concentrations 
(P = 0.01; Table 3; Fig. 2). Saturated fat was signifi-
cantly protective against high VLDL-C levels over 
the whole sample, but this effect was only seen at 
lower carbohydrate intakes—the association between 
saturated fat and low VLDL-C was not significant in 
the highest tertile of carbohydrate intake.
In addition, there was a significant interaction 
(P = 0.02; Table 3, Fig. 4) between carbohydrates and 
saturated fat on fasting HDL-C concentrations, although 
this showed a slightly different pattern of results. 
Although overall saturated fat intake did not show a 
main effect on HDL-C levels in the model (P = 0.14), 
higher saturated fat was associated with lower HDL-C 
in the highest tertile of carbohydrate intake (Fig. 4).
Table 3. Parameter estimates from mixed linear regression 
models examining the associations between carbohydrate 
intake, saturated fat intake and an interaction between 
carbohydrate and saturated fat intake on plasma lipids.*
Beta (β) se P-value
TGs
carbohydrate intake -0.005 0.01 0.56
Saturated fat intake -0.05 0.03 0.08
Interaction term 0.001 0.001 0.04
VLDL-C
carbohydrate intake -0.01 0.01 0.25
Saturated fat intake -0.09 0.04 0.01
Interaction term 0.002 0.001 0.01
LDL-c
carbohydrate intake -0.01 0.01 0.41
Saturated fat intake -0.01 0.04 0.75
Interaction term -0.0002 0.001 0.76
HDL-c
carbohydrate intake -0.005 0.005 0.31 
Saturated fat intake -0.02 0.01 0.14
Interaction term 0.001 0.0003 0.02
Notes: *Models control for sex, age, smoking status, alcohol intake, study 
site, BMI, overall food energy intake, glycemic load of diet and percentage 
energy from transfats, polyunsaturated fatty acids, monounsaturated 
fatty acids and protein.
Abbreviations: Tgs, Triglycerides; VLDL-c, Very low density lipoprotein 
































Figure 1. Triglyceride (Tg) concentrations by carbohydrate intake 
 tertiles, split into high and low saturated fat intake.
Note: Tg concentrations are predicted values after log transformed Tg 
values were regressed for the potential effects of sex, age, smoking sta-
tus, alcohol intake, centre of data collection, BMI, blood pressure, overall 
food energy intake, glycemic load of diet and percentage intakes of trans- 
fats, PUFAs, MUFAs and protein. exact P-values for each parameter can 
be found in Table 3.
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Figure 2. Very low density cholesterol (VLDL-c) concentrations by car-
bohydrate intake tertiles, split into high and low saturated fat intake.
Note: VLDL-c concentrations are predicted values after log transformed 
VLDL-c values were regressed for the potential effects of sex, age, 
smoking status, alcohol intake, centre of data collection, BMI, blood pres-
sure, overall food energy intake, glycemic load of diet and percentage 
intakes of trans- fats, PUFAs, MUFAs and protein. exact P-values for 
each parameter can be found in Table 3.
carbohydrate intake, saturated fat and cholesterol
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We did not observe significant interactions between 
carbohydrate and saturated fat intake on LDL-C 
(P = 0.76; Table 3, Fig. 3).
Discussion
We aimed to investigate the relationship between 
dietary saturated fat intake, dietary carbohydrate 
intake and fasting lipids. When not controlling 
for carbohydrate intake, there was no association 
between saturated fat intake and TG or any fraction 
of cholesterol. However, when models accounted 
for the mediation of saturated fat on lipids by car-
bohydrate intake, we then found a significant asso-
ciation between higher saturated fat intake and lower 
VLDL-C (P = 0.01), and a significant interaction 
(P = 0.01) between the two macronutrients. This inter-
action revealed that the overall association between 
higher saturated fat and lower VLDL-C disappeared 
at higher intakes of dietary carbohydrate. The asso-
ciations between saturated fat intake and TGs were 
similar to those for VLDL-C, except the overall asso-
ciation between saturated fat and TG did not quite 
reach significance (P = 0.08). The potential benefit of 
a reduction in TG and VLDL-C concentrations asso-
ciated with increased saturated fat intakes at lower 
carbohydrate levels, were off-set by high saturated 
fat being associated with lower HDL-C (the “good” 
cholesterol) at lower carbohydrate intakes.
Despite early epidemiological studies reporting 
increased saturated fat to be associated with increased 
TG and VLDL-C concentrations,3–10 data are emerg-
ing showing no association between saturated fat and 
CVD risk,20–24 with a recent meta-analysis on pro-
spective data concluding there was no association 
between saturated fat intake and CVD risk across 
studies.25 Indeed a recent study on Japanese men 
showed that saturated fat was associated with a low-
ering of LDL-C, although this did not reach statis-
tical significance.26 However, the issue of whether 
saturated fat intake is associated with dyslipidemia 
remains controversial; individual differences such as 
age or gender have been shown to affect the relation-
ship between saturated fat and coronary heart disease7 
and the nature and direction of the relationship was 
debated in a recent issue of the American Journal of 
Clinical Nutrition.27,28 Our data support the newer 
line of evidence showing association of saturated 
fat on lipids, when carbohydrate consumption is not 
accounted for.
It is frequently observed that diets where fat is 
substituted for carbohydrate, increase fasting TGs 
and their precursors.29,30 As this is not always the 
finding from studies28 the need to continue to inves-
tigate this relationship is emphasized. Our results 
support data that show higher dietary saturated fat to 
be associated with lower fasting VLDL-C and TG. 
However, we additionally show that this associa-
tion is not seen at a high carbohydrate intake. This 
confirms in a large, epidemiological “free-living” 
design, the inference of results from exchange stud-
ies where exchanging fat for carbohydrate increases 
TG and VLDL-C, and exchanging carbohydrate for 
fat has the reverse effects.16,27,29–31 To our knowledge, 
no study has yet examined whether carbohydrates 
mediate the effects of saturated fat on fasting lipids 
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Figure 4. high density cholesterol (hDL-c) concentrations by carbohy-
drate intake tertiles, split into high and low saturated fat intake.
Note: LDL-c concentrations are predicted values after regression for the 
potential effects of sex, age, smoking status, alcohol intake, centre of 
data collection, BMI, blood pressure, overall food energy intake, glycemic 
load of diet and percentage intakes of trans- fats, PUFAs, MUFAs and 
protein. exact P-values for each parameter can be found in Table 3.
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Figure 3. Low density cholesterol (LDL-c) concentrations by carbohy-
drate intake tertiles, split into high and low saturated fat intake.
Note: LDL-c concentrations are predicted values after regression for the 
potential effects of sex, age, smoking status, alcohol intake, centre of 
data collection, BMI, blood pressure, overall food energy intake, glycemic 
load of diet and percentage intakes of trans- fats, PUFAs, MUFAs and 
protein. exact P-values for each parameter can be found in Table 3.
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using an  epidemiological design, and we suggest 
that failing to account for an interaction between the 
two macronutrients may have mask the link between 
lower VLDL-C and TG and saturated fat.
A diet high in carbohydrates may interact with 
saturated fat through two possible pathways: (1) post 
prandial clearance mechanisms that arise from high 
fructose corn syrup (HFCS). HFCS is the most 
commonly used sweetener in the United States and 
may therefore account for a considerable amount of 
dietary carbohydrates. It has been shown that fruc-
tose, and HFCS leads to higher postprandial TG 
 concentrations.32 This raise in postprandial TG is 
believed to occur enhanced de novo lipogensis via the 
activation of sterol regulatory element binding protein 
1-c (SREBP-1c) and carbohydrate response element 
binding protein (ChREB), a nuclear transcription 
factor that has been suggested to mediate the effects 
of fructose.33 Alternatively, (2) decreased clearance 
of VLDL-TG. This occurs through the ingestion of 
carbohydrate,18 and may additionally be mediated 
through increased insulin resistance which arises 
from a higher carbohydrate intake.34 This hypothesis 
is supported by research on the effect of the glyce-
mic load (GL) of the diet. Lower GL diets result in a 
slower, steadier release of insulin, with a lower over-
all peak. New research suggests that the effects of 
increasing carbohydrate intake in TG and VLDL-C 
levels may based on the type of carbohydrate that is 
increased; replacement of saturated fat with low GL 
carbohydrates may not show this effect,35 indicating 
that the effects of carbohydrates on lipoproteins may 
be insulin mediated. Given the potential role of insu-
lin resistance in mediating the effects of saturated fat 
on lipoproteins, it would be of interest to repeat the 
current analysis in diabetic, or pre-diabetic patients, 
which is not possible in the current sample due to a 
lack of power. Although a fuller assessment of the 
role of insulin resistance in mediating the metabolism 
of carbohydrate and saturated fat is beyond the scope 
of the current analysis, we do report that homeostatic 
model assessment of insulin resistance (HOMA-IR) 
was significantly predicted by saturated fat intake 
(P = 0.11), carbohydrate intake (P = 0.99) nor was 
there an interaction between saturated fat and carbo-
hydrate intake on HOMA-IR (P = 0.56).
Our results do entirely concur with previous data; 
some data have shown that that high carbohydrate 
intake is associated with higher TG and VLDL-C,16 
which we do not see in our data. The reasons for this 
are not clear, but could reflect either the healthy study 
population, the effects of longer term dietary patterns, 
or the overall high carbohydrate intake of the partici-
pants (with the lowest tertile of carbohydrate intake 
averaging 40% of energy intake from carbohydrate), 
when compared to controlled exchange studies that 
can be more restrictive. In addition the average age 
of our participants was 49 years, and the relationship 
between saturated fat and lipids may be age depen-
dent warranting replication in a younger cohort.7
Thus, the results from this study need to be viewed 
in light of a number of limitations. First, we used 
existing data from a cross-sectional study, so were 
unable to establish any causal association. Secondly, 
dietary intakes were assessed once with a food-
 frequency  questionnaire which has some inherent 
errors. Although this instrument has been validated in 
other US populations, it has not been validated spe-
cifically for our study population. Finally, we did not 
have data on potential dietary mediators, nor did we 
analyze other health outcomes in relation to saturated 
fat intake, making us unable to make general public 
health recommendations. A potential dietary media-
tor of interest would be the type of carbohydrate 
intake (although overall GL of the diet was included 
as a covariate in the regression models). This would 
be a useful avenue for future research, given that 
whole grains may confer protective effects on TG and 
VLDL-C concentrations36,37 while simple sugars and 
highly refined grains confer more detrimental effects.38 
The exchange of high GL carbohydrate sources, 
such as simple sugars, for lower GL sources, such as 
whole grains, confers lipid profile benefits in addition 
to lower fasting insulin levels39 and reduced insulin 
resistance,40 emphasizing the need to investigate the 
role of insulin in the interaction between carbohydrate 
and saturated fat intake that we report here. In terms 
of health outcomes other than lipid profile, although 
we controlled for BMI, we were unable to examine 
other correlates of saturated fat intake, such as liver 
function, which would be another important avenue 
for future research, However, the GOLDN study pro-
vided an opportunity to study the relation between 
macronutrients and lipids across a broad spectrum of 
weight and clinical characteristics, and focus on habit-
ual dietary intake in a non controlled way.
carbohydrate intake, saturated fat and cholesterol
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We also note that it not clear whether carbohydrate 
induced TG and VLDL-C levels confer the same 
atherogenic risk as other elevations in TG,29,30,41–43 and 
this requires further investigation.
There is importance in understanding the path-
ways through which macronutrient intakes affect dys-
lipidemia and CVD. We recommend future studies 
replicate these findings and examine the differential 
roles of different types of carbohydrate in mediating 
saturated fat intake on dyslipidemia. Overall, our data 
suggest that the role of saturated fat in dyslipidemia is 
mediated through carbohydrate intake, which if vali-




1328 men and women were recruited and screened 
for the in the GOLDN study population. All partici-
pants were white men and women recruited from 
Minneapolis, Minnesota and Salt Lake City, Utah. 
The details of the GOLDN study have been published 
elsewhere.44 Subsequent to recruitment, we excluded 
data from participants who were unwilling to stop 
lipid lowering pharmacological interventions, those 
with a self-reported history of kidney or Grave’s dis-
ease and those in the top and lowest one percentile of 
total energy intake. In addition, those with missing 
data on potential confounders were excluded leav-
ing a final sample for analysis of 1036 individuals 
across 187 families, consisting of 497 men and 539 
women (mean ± SD = 48.8 ± 16.2 years of age). The 
primary aim of the GOLDN study was to characterize 
the role of genetic and dietary factors on an individ-
ual’s response to a high fat diet and fenofibrate. The 
protocol for this study was approved by the Institu-
tional Review Boards at the University of Minnesota, 
University of Utah, Tufts University/New England 
Medical Center and the University of Alabama at 
Birmingham. Written informed consent was obtained 
from all participants in accordance with the ethical 
standards of both data collection sites.
Data collection
Clinical characteristics, including anthropometric 
and blood-pressure measurements, were taken at 
the study clinics where a fasting blood sample was 
also drawn as described previously.44 Questionnaires 
were administered to collect demographic data and 
information on lifestyle attributes and medical history.
Dietary intake
We used the Diet History Questionnaire (DHQ) 
developed by the National Cancer Institute to assess 
habitual dietary intake. This instrument is a Food Fre-
quency Questionnaire that measures habitual dietary 
intake over the preceding six months. The DHQ was 
validated against four 24-hr dietary recalls for ability 
to assess dietary intake and showed an average cor-
relation of 0.62.45
Biochemical measurements
All plasma samples were analyzed together at the end 
of the study. Measurements of plasma TG, VLDL-C, 
LDL-C and HDL-C were determined using enzymatic 
assays as previously described.46
Statistical analysis
Statistical analyses were carried out using SAS for 
Windows, version 9.2 (SAS Institute, Cary, NC).
Before running multivariate linear mixed models 
to examine main effects and potential interactions 
between carbohydrate and saturated fat intake on fast-
ing lipids, levels of potential confounders across car-
bohydrate intake levels were examined. For this initial, 
exploratory analysis, carbohydrate intake was divided; 
the ordered distribution (ordered by percentage of the 
dietary intake as carbohydrate) of the study popula-
tion was divided into tertiles. The significance of dif-
ferences in the distribution of continuous variables, by 
carbohydrate tertile, was examined using linear mixed 
models that adjusted for correlations within pedigrees. 
The significance of categorical variables was tested 
using a 2-df chi-squared test of difference. Means and 
standard errors reported are for raw data.
To maximize power, carbohydrate and saturated 
fat intake were used in multilevel mixed models as 
continuous variables. Unlike HDL-C and LDL-C 
which were normally distributed, TG and VLDL-C 
had skewed distribution and were log-transformed. 
The association between saturated fat and plasma 
lipids and the interaction between carbohydrate and 
saturated fat on lipids, both expressed as percent of 
total energy intake, were tested using a mixed model 
implemented in the Mixed Procedure in SAS (SAS 
institute, Cary, NC).
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Potential confounders were adjusted for in a step-
wise fashion. The following separate models were 
run sequentially. The outcome variable was the lipid 
(or TG), and predictor variables were:
1. Saturated fat.
2. Saturated fat, age and sex. Both are expected to 
confound with lipids 47 and show significant dif-
ferences across potential confounders in the current 
study (Table 1) and across tertiles of carbohydrate 
intake (Table 2);
3. Saturated fat, age, sex and smoking, alcohol and 
BMI. Alcohol and BMI showed significant dif-
ferences across tertiles of carbohydrate intake 
(P , 0.05; Table 2);
4. Saturated fat, age, sex, smoking, alcohol, BMI and 
fat intake broken into trans-, PUFA and MUFA 
fat intake differed across tertiles of carbohydrate 
intake (P , 0.001; Table 2);
5. Saturated fat, age and sex, smoking, alcohol and 
BMI, fat intake and type of carbohydrate intake 
as measured by GL. GL may confer differential 
effects on fasting lipids across the distribution;39,40
6. Saturated fat, age, sex, smoking, alcohol and BMI, 
fat intake, type of carbohydrate intake and per-
centage of the diet as protein. Protein was added 
given recent findings on the thermogenic effect of 
protein;48
7. Saturated fat, age, sex, smoking, alcohol and BMI, 
fat intake, type of carbohydrate intake, percentage 
of the diet as protein and systolic and diastolic blood 
pressure, taken at the time of the blood draw,
After looking for a main effect of saturated fat 
on lipids, the models were rerun including carbohy-
drate as a predictor variable and an interaction term 
between carbohydrate and saturated fat. The direction 
and significance (with an alpha of P , 0.05) of results 
did not change between models 2–6 for both sets of 
analyses, so results from the “fully adjusted” models 
that control for age, sex, smoking, alcohol and BMI, 
fat intake, type of carbohydrate intake and percentage 
of the diet as protein as covariates are presented.
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